Search results for " ASTHMA"

showing 10 items of 300 documents

Environmental Isocyanate-Induced Asthma: Morphologic and Pathogenetic Aspects of an Increasing Occupational Disease

2011

Occupational diseases affect more and more people every year. According to the International Labour Organization (ILO), in 2000 an estimated amount of at least 160 million people became ill as a result of occupational-related hazards or injuries. Globally, occupational deaths, diseases and injuries account for an estimated loss of 4% of the Gross Domestic Product. Important substances that are related to occupational diseases are isocyanates and their products. These substances, which are used in a lot of different industrial processes, are not only toxic and irritant, but also allergenic. Although the exposure to higher concentrations could be monitored and restricted by technical means, v…

Early signsHealth Toxicology and MutagenesisOccupational diseaselcsh:MedicineDiseaseReviewAir Pollutants OccupationalIsocyanate induced asthmaToxicologyRisk groupsEnvironmental healthOccupational ExposuremedicineGenetic predispositionHumansGenetic Predisposition to Diseasepathological findingsAsthma OccupationalVolume concentrationbusiness.industrylcsh:RPublic Health Environmental and Occupational Healthclinical findingsAllergensmedicine.diseaseoccupational diseaseisocyanatebusinessoccupational asthmaOccupational asthmagenetic predispositionIsocyanatesInternational Journal of Environmental Research and Public Health
researchProduct

Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes

2021

Funder: Global Initiative for Asthma

ExacerbationRespiratory SystemINHALED CORTICOSTEROIDSCritical Care and Intensive Care MedicineAsthma managementSINGLE-INHALERDOUBLE-BLINDRisk Factorsimmune system diseasesAdrenal Cortex HormonesRELIEVER THERAPYFormoterol FumarateMedicine and Health SciencesImmunology and AllergyAnti-Asthmatic AgentsChild11 Medical and Health SciencesLung functionMILD PERSISTENT ASTHMAExecutive summaryBiologic therapiesCombined Modality TherapyLUNG-FUNCTIONChild PreschoolPractice Guidelines as TopicPerspectiveDisease ProgressionDrug Therapy Combinationmedicine.drugPulmonary and Respiratory MedicineAdultmedicine.medical_specialtyBUDESONIDE/FORMOTEROL MAINTENANCEAdolescentMild asthmaMEDLINEInhaled corticosteroidsCONTROLLED-TRIALSkills trainingGINA Strategy 2021: Executive SummaryBUDESONIDE-FORMOTEROLAdministration InhalationmedicineHumansasthma preventionIntensive care medicineSEVERE EXACERBATIONSAsthmaasthma diagnosisbusiness.industryPatient AcuityInfantasthmamedicine.diseaseAsthmarespiratory tract diseasesSelf Carewf_140Formoterolwf_100businessasthma management
researchProduct

Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma

2018

Asthma is a very frequent chronic airway disease that includes many different clinical phenotypes and inflammatory patterns. In particular, eosinophilic bronchial inflammation is often associated with allergic as well as nonallergic asthma. The most important cytokine involved in the induction, maintenance, and amplification of airway eosinophilia in asthma is interleukin-5 (IL-5), released by both T helper 2 (Th2) lymphocytes and group 2 innate lymphoid cells (ILC2). Hence, IL-5 and its receptor are suitable targets for selective biologic drugs which can play a key role in add-on treatment of severe eosinophilic asthma refractory to corticosteroids. Within such a context, the anti-IL-5 mon…

Genetics and Molecular Biology (all)0301 basic medicineImmunology and Microbiology (all)lcsh:MedicineReview ArticleAntibodies Monoclonal HumanizedBiochemistryAntibodiesGeneral Biochemistry Genetics and Molecular Biology03 medical and health scienceschemistry.chemical_compoundTh2 Cells0302 clinical medicineReslizumabMonoclonalEosinophilicmedicineAnimalsHumansEosinophiliaHumanizedInterleukin 5AsthmaGeneral Immunology and Microbiologybusiness.industrylcsh:RInnate lymphoid cellGeneral Medicinemedicine.diseaseBenralizumabAsthmarespiratory tract diseasesBiological Therapy030104 developmental biology030228 respiratory systemchemistryImmunologyInterleukin-5medicine.symptombusinessMepolizumabAnimals; Antibodies Monoclonal Humanized; Asthma; Biological Therapy; Humans; Interleukin-5; Th2 Cells; Biochemistry Genetics and Molecular Biology (all); Immunology and Microbiology (all)medicine.drug
researchProduct

Assessment of large and small airways wall thickness by HRCT in asthma

2010

Purpose Methods and Materials Results Conclusion References Personal Information

HRCT AsthmaThoraxChest - LungLungRespiratory systemAirways wall thickne
researchProduct

Climate Change and Childhood Respiratory Health: A Call to Action for Paediatricians

2020

Climate change (CC) is one of the main contributors to health emergencies worldwide. CC appears to be closely interrelated with air pollution, as some pollutants like carbon dioxide (CO2), nitrogen oxides (NOx) and black carbon are naturally occurring greenhouse gases. Air pollution may enhance the allergenicity of some plants and, also, has an adverse effect on respiratory health. Children are a uniquely vulnerable group that suffers disproportionately from CC burden. The increasing global warming related to CC has a big impact on plants’ lifecycles, with earlier and longer pollen seasons, as well as higher pollen production, putting children affected by asthma and allergic rhinitis at ris…

Health Toxicology and MutagenesisChild WelfareClimate changelcsh:MedicineReview010501 environmental sciencesHealth outcomes01 natural sciences03 medical and health sciencesExtreme weatherrespiratory infections0302 clinical medicineSettore MED/38 - Pediatria Generale E SpecialisticachildrenAir PollutionEnvironmental healthHypersensitivityHumansMedicinePediatricians030212 general & internal medicineChildAdverse effectRespiratory health0105 earth and related environmental sciencesAsthmaallergic rhinitisbusiness.industryGlobal warminglcsh:RPublic Health Environmental and Occupational Healthallergic rhinitis; asthma; children; climate change; paediatricians; respiratory infectionsAllergensasthmamedicine.diseasepaediatricianCall to actionclimate changebusinessallergic rhinitipaediatricians
researchProduct

Near-fatal asthma phenotype in the ENFUMOSA Cohort.

2007

Summary Background Near-fatal asthma (NFA) is characterized by severe asthma attacks usually requiring intensive care unit admission. This phenotype of asthma has been studied mainly in acute conditions. Methods The aim of our study was to compare the clinical, functional and inflammatory characteristics of NFA patients with mild to severe asthmatics in stable conditions. We recruited 155 asthmatic patients from five centres of the European Network for Understanding Mechanisms of Severe Asthma: 67 patients with mild-to-moderate asthma controlled by low/medium doses of inhaled corticosteroids; 64 with severe asthma that, despite treatment with high doses of inhaled corticosteroids, long-acti…

Hypersensitivity ImmediateMaleAllergyVital CapacityAnti-asthmatic AgentSeverity of Illness Indexlaw.inventionCohort StudiesLeukocyte CountlawRisk FactorsForced Expiratory Volumenear-fatal asthmaImmunology and AllergyMedicineAnti-Asthmatic AgentsMiddle AgedIntensive care unitInflammation near-fatal asthma severe asthma sputumPhenotypeFemalemedicine.symptomCohort studyAdultinflammation; near-fatal asthma; severe asthma; sputumsevere asthmamedicine.medical_specialtyPartial PressureImmunologyStatus AsthmaticusDrug Administration ScheduleInternal medicineSeverity of illnessHumansRisk factorGlucocorticoidsAsthmaSkin TestsInflammationbusiness.industrysputummedicine.diseaseAsthmarespiratory tract diseasesOxygeninflammationImmunologySputumPatient Compliancebusiness
researchProduct

Serum soluble interleukin-2 receptor (IL-2R) in children with allergic disorders

1993

Hypersensitivity ImmediateSolubilityChild PreschoolEczemaHumansInfantReceptors Interleukin-2Immunoglobulin EChildInfant; Solubility; Immunoglobulin E; Humans; Hypersensitivity Immediate; Asthma; Child; Receptors Interleukin-2; Eczema; Child PreschoolAsthmaHuman
researchProduct

IL-17 and Th17-cells as markers of disease progression in pediatric allergic diseases. A therapeutic approach in an “in vitro” model

2011

Rationale: Th17 cells and IL-17 play a role in allergy development and progression. Objective: To investigate whether IL-17-producing Th17 cells characterized systemic and airway inflammation in children with concomitant allergic rhinitis and asthma and whether Budesonide (Bud) and Formoterol (Form), alone or in combination, might provide a therapeutic strategy for controlling the inflammatory events associated with IL-17. Methods: We tested IL-17 levels in plasma (P), nasal wash (NW) and induced sputum (IS) from healthy (HC) and asthmatic children (intermittent=IA or mild-moderate=MA) with concomitant rhinitis (intermittent=IR or persistent=PR). Then we tested the expression of intracellul…

IL-17allergic rhinitis and asthma RORt FOXP3
researchProduct

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

2020

According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managing corticosteroid-related diseases, oral corticosteroid sparing up to withdrawal should be considered a primary outcome in the management of severe asthma. New biologics have clearly demonstrated that this effect is possible, with concomitant reduction in the rate of exacerbations and in symptom control. Then, there is no reason for using so frequently oral corticosteroid before having explored al…

ISAR International Severe Asthma RegistrySHARPPediatricsSevere asthmaSA severe asthmaBiologics Oral corticosteroids Real-life Registr Severe asthmaOmalizumabforced expiratory volume in the 1st secondFood &ampGrading of Recommendations Assessmentchronic rhinosinusitis with nasal polyposisFEV1chemistry.chemical_compound0302 clinical medicineQuality of lifeEMAReal WorldEuropean Medicines AgencyBiologics; Oral corticosteroids; Real-life; Registr; Severe asthmaOral corticosteroidsFDA Food & Drug AdministrationImmunology and Allergy030223 otorhinolaryngologySevere Heterogeneous Asthma Research collaborationmusculoskeletal neural and ocular physiologyReal-lifeCRSwNPOCSsBenralizumabDupilumabCRSwNP chronic rhinosinusitis with nasal polyposisGRADESHARP Severe Heterogeneous Asthma Research collaboration Patient-centredSevere Asthma Network in ItalyFDAmedicine.drugPulmonary and Respiratory Medicinelcsh:Immunologic diseases. Allergymedicine.medical_specialtyDrug AdministrationGINA Global Initiative for AsthmaRW Real WorldImmunologymacromolecular substancesRWSettore MED/10 - Malattie Dell'Apparato RespiratorioBiologicsInternational Severe Asthma RegistryISAR03 medical and health sciencesSADisease registrySARP Severe Asthma Research ProgramPatient-centredmedicineAsthmabusiness.industrySettore MED/09 - MEDICINA INTERNASANI Severe Asthma Network in ItalySANIBiological productmedicine.diseaseOCSs Oral CorticoSteroidsGINASARPSevere Asthma Research ProgramFEV1 forced expiratory volume in the 1st second030228 respiratory systemchemistrynervous systemRegistrEMA European Medicines AgencyDevelopment and EvaluationSevere asthma Biologics Oral corticosteroids Real-life Registrbusinesslcsh:RC581-607Global Initiative for AsthmaMepolizumabGRADE Grading of Recommendations Assessment Development and Evaluation
researchProduct

Cucumis sativus l. Seeds ameliorate muscular spasm-induced gastrointestinal and respiratory disorders by simultaneously inhibiting calcium mediated s…

2021

Cucumis sativus L. is globally cultivated as an edible vegetable. Besides its nutritional benefits, it is used in traditional medicines against various ailments. The current study was designed to elucidate the multi-target mechanisms of a C. sativus seeds extract against asthma and diarrhea using network pharmacology along with a molecular docking approach. Furthermore, in-vitro and in-vivo experiments were conducted to verify the mechanistic insight of in silico studies. LC-ESI-MS/MS was performed to identify the bioactive compounds in the extract; later, some compounds were quantified by HPLC. C. sativus seed. EtOH has kaempferol in higher concentration 783.02 µg/g, followed by quercetin …

In silicoPharmaceutical Sciencechemistry.chemical_elementPharmacologyCalciumArticleJejunum<i>Cucumis sativus</i>chemistry.chemical_compoundAntidiarrheal; Asthma; Bronchodilator; Cucumber; Cucumis sativus; HPLC; LC-ESI-MS/MSPharmacy and materia medicaAntidiarrhealDrug Discoverymedicinebiologyasthma; antidiarrheal; bronchodilator; <i>Cucumis sativus</i>; cucumber; HPLC; LC-ESI-MS/MSCucumberRfood and beveragesLC-ESI-MS/MSbiology.organism_classificationAsthmaRS1-441medicine.anatomical_structurechemistryMolecular MedicineMedicineSignal transductionCucumis sativusHPLCKaempferolQuercetinCucumisLuteolinBronchodilator
researchProduct